GeneDx Holdings (WGSWW) Total Liabilities (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Total Liabilities data on file, last reported at $252.2 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $252.2 million, up 33.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $252.2 million (up 33.41% YoY), and the FY2025 annual result was $215.5 million, up 23.77% from the prior year.
• Total Liabilities rose to $252.2 million in Q1 2026 per WGSWW's latest filing, from $215.5 million in the prior quarter.
• Over five years, Total Liabilities peaked at $296.0 million in Q2 2022 and troughed at $163.0 million in Q3 2023.
• A 5-year average of $208.6 million and a median of $195.1 million in 2024 frame the typical range for Total Liabilities.
• On a YoY basis, Total Liabilities climbed as much as 42.92% in 2022 and fell as far as 53.72% in 2022.
• A 5-year view of Total Liabilities shows it stood at $237.2 million in 2022, then dropped by 19.6% to $190.7 million in 2023, then declined by 8.71% to $174.1 million in 2024, then rose by 23.77% to $215.5 million in 2025, then rose by 17.0% to $252.2 million in 2026.
• Business Quant data shows WGSWW's Total Liabilities at $252.2 million in Q1 2026, $215.5 million in Q4 2025, and $201.6 million in Q3 2025.